Zota Health Care Stock Current Valuation
| ZOTA Stock | 685.90 23.10 3.49% |
Valuation analysis of Zota Health Care helps investors to measure Zota Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Zota Health's Cash And Short Term Investments are comparatively stable compared to the past year. Cash And Equivalents is likely to gain to about 14.9 M in 2024, despite the fact that Change In Cash is likely to grow to (1 M). Fundamental drivers impacting Zota Health's valuation include:
Price Book 19.7037 | Enterprise Value 18.7 B | Enterprise Value Ebitda 337.2921 | Price Sales 8.9475 | Enterprise Value Revenue 9.4233 |
Overvalued
Today
Please note that Zota Health's price fluctuation is very steady at this time. Calculation of the real value of Zota Health Care is based on 3 months time horizon. Increasing Zota Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Zota stock is determined by what a typical buyer is willing to pay for full or partial control of Zota Health Care. Since Zota Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zota Stock. However, Zota Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 685.9 | Real 605.72 | Hype 685.66 |
The intrinsic value of Zota Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Zota Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Zota Health Care helps investors to forecast how Zota stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zota Health more accurately as focusing exclusively on Zota Health's fundamentals will not take into account other important factors: Zota Health Care Company Current Valuation Analysis
Zota Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Zota Health Current Valuation | 18.67 B |
Most of Zota Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zota Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Zota Health Care has a Current Valuation of 18.67 B. This is 29.99% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is 12.31% lower than that of the firm.
Zota Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zota Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zota Health could also be used in its relative valuation, which is a method of valuing Zota Health by comparing valuation metrics of similar companies.Zota Health is currently under evaluation in current valuation category among its peers.
Zota Fundamentals
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.0405 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 18.67 B | ||||
| Shares Outstanding | 25.85 M | ||||
| Price To Book | 19.70 X | ||||
| Price To Sales | 8.95 X | ||||
| Revenue | 1.8 B | ||||
| Gross Profit | 572.41 M | ||||
| EBITDA | 82.07 M | ||||
| Net Income | (143.48 M) | ||||
| Cash And Equivalents | 10.23 M | ||||
| Total Debt | 952.85 M | ||||
| Book Value Per Share | 35.76 X | ||||
| Cash Flow From Operations | (50.82 M) | ||||
| Earnings Per Share | (9.26) X | ||||
| Number Of Employees | 445 | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 17.73 B | ||||
| Total Asset | 2.28 B | ||||
| Retained Earnings | (17.53 M) | ||||
| Working Capital | 379.33 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 2.28 B |
About Zota Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zota Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zota Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zota Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Zota Stock Analysis
When running Zota Health's price analysis, check to measure Zota Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zota Health is operating at the current time. Most of Zota Health's value examination focuses on studying past and present price action to predict the probability of Zota Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zota Health's price. Additionally, you may evaluate how the addition of Zota Health to your portfolios can decrease your overall portfolio volatility.